The role of EphA2 in KRAS mutant non-small cell lung cancer

被引：0
|
作者：
Amato, Katherine [1 ]
Wang, Shan [1 ]
Hastings, Andrew [1 ]
Chen, Haiying [2 ]
Colvin, Daniel [1 ]
Ye, Fei [1 ]
Chen, Jin [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] Univ Melbourne, Melbourne, Vic, Australia
来源：
MOLECULAR CANCER RESEARCH | 2014年 / 12卷
关键词：
D O I：
10.1158/1557-3125.RASONC14-A01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A01
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer
    Li, Yunchang
    Hu, Lanlin
    Peng, Xinhao
    Xu, Huasheng
    Tang, Bo
    Xu, Chuan
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 129 - 146
  • [32] Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non-Small Cell Lung Cancer
    Shimamura, Takeshi
    Chen, Zhao
    Soucheray, Margaret
    Carretero, Julian
    Kikuchi, Eiki
    Tchaicha, Jeremy H.
    Gao, Yandi
    Cheng, Katherine A.
    Cohoon, Travis J.
    Qi, Jun
    Akbay, Esra
    Kimmelman, Alec C.
    Kung, Andrew L.
    Bradner, James E.
    Wong, Kwok-Kin
    CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6183 - 6192
  • [33] KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
    Xie, Mingying
    Xu, Xiaoling
    Fan, Yun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] EPHA2 Interacts with DNA-PKcs in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
    Kaminskyy, Vitaliy O.
    Haag, Petra
    Novak, Metka
    Vegvari, Akos
    Arapi, Vasiliki
    Lewensohn, Rolf
    Viktorsson, Kristina
    CANCERS, 2021, 13 (05) : 1 - 23
  • [35] Frequency of KRAS Subtypes in Non-Small Cell Lung Cancer
    Biernacka, Anna
    Tsongalis, Peter D.
    Peterson, Jason D.
    de Abreu, Francine
    Black, Candice C.
    Gutmann, Edward
    Liu, Xiaoying
    Padmanabhan, Vijayalakshmi
    Tafe, Laura J.
    Amos, Christopher I.
    Tsongalis, Gregory J.
    MODERN PATHOLOGY, 2016, 29 : 451A - 451A
  • [36] EpHA2 is an essential driver of invasion and a novel target in KRAS mutant colorectal cancer
    Dunne, Philip D.
    McArt, Darragh G.
    Blayney, Jaine K.
    Dasgupta, Sonali
    Salto-Tellez, Manuel
    Johnston, Patrick G.
    Van Schaeybroeck, Sandra
    CANCER RESEARCH, 2014, 74 (19)
  • [37] Current perspectives of KRAS in non-small cell lung cancer
    Harris, Ethan
    Thawani, Rajat
    CURRENT PROBLEMS IN CANCER, 2024, 51
  • [38] Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
    Tomasini, Pascale
    Walia, Preet
    Labbe, Catherine
    Jao, Kevin
    Leighl, Natasha B.
    ONCOLOGIST, 2016, 21 (12): : 1450 - 1460
  • [39] KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition
    Adderley, Helen
    Blackhall, Fiona H.
    Lindsay, Colin R.
    EBIOMEDICINE, 2019, 41 : 711 - 716
  • [40] Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer
    Wang, Yadong
    Peng, Ling
    Zhao, Ming
    Xiong, Yuanyuan
    Xue, Jianchao
    Li, Bowen
    Huang, Zhicheng
    Liu, Xinyu
    Yang, Xiaoying
    Song, Yang
    Bing, Zhongxing
    Guo, Chao
    Tian, Zhenhuan
    Gao, Chao
    Cao, Lei
    Cao, Zhili
    Li, Ji
    Jiang, Xu
    Si, Xiaoyan
    Zhang, Li
    Li, Xiaoguang
    Zheng, Zhibo
    Song, Mengmeng
    Chen, Rongrong
    Lim, Wan-Teck
    Pavan, Alberto
    Romero, Atocha
    Liang, Naixin
    Yang, Huaxia
    Li, Shanqing
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (09) : 1936 - +
12345